Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM)

CUSIP: 14216R101

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
41,966,083
Total 13F shares
5,575,722
Share change
-46,807
Total reported value
$1,728,189
Price per share
$0.31
Number of holders
36
Value change
-$36,721
Number of buys
10
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 14216R101?
CUSIP 14216R101 identifies CARM - Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q1 2025

As of 31 Mar 2025, Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,575,722 shares. The largest 10 holders included Merck & Co., Inc., VANGUARD GROUP INC, AJU IB Investment Co., Ltd., BARCLAYS PLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Universal- Beteiligungs- und Servicegesellschaft mbH, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 36 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.